Research and development of treatments using medical radioisotopes and nuclear medicine treatments has progressed rapidly in countries around the world in recent years.

We will confirm the current status of clinical research on Ac-225, which is attracting particular attention, and share the current status of supply-demand matching for Ra-226, which is the raw material for Ac-225, and give a stir to discussions aimed at building win-win relationships with countries around the world. This event is organized by Japan.

This event will be held on Tuesday, 16 September 2025, from 4.30 p.m. to 6.00 p.m. in Conference Room M7, M Building, ground floor.